Literature DB >> 348036

Otitis media: the spectrum of middle ear inflammation.

G S Giebink, P G Quie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 348036     DOI: 10.1146/annurev.me.29.020178.001441

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  7 in total

1.  Effect of middle ear fluid on sound transmission and auditory brainstem response in guinea pigs.

Authors:  Xiying Guan; Rong Z Gan
Journal:  Hear Res       Date:  2011-03-21       Impact factor: 3.208

2.  Indigenous nasopharyngeal, auditory canal, and middle ear bacterial flora of gerbils: animal model for otitis media.

Authors:  T A Thompson; D Gardner; R S Fulghum; H J Daniel; W E Allen; J M Worthington; P P Williams
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

3.  Sulfisoxazole chemoprophylaxis and recurrent otitis media.

Authors:  T E Liston; R Harbison
Journal:  West J Med       Date:  1984-01

4.  Experimental otitis media in gerbils and chinchillas with Streptococcus pneumoniae, Haemophilus influenzae, and other aerobic and anaerobic bacteria.

Authors:  R S Fulghum; J E Brinn; A M Smith; H J Daniel; P J Loesche
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

5.  Otitis media caused by beta-lactamase-producing Branhamella (Neisseria) catarrhalis.

Authors:  W S Lee; T Fordham; J Alban
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

6.  Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas.

Authors:  G S Giebink; I K Berzins; S C Marker; G Schiffman
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

7.  Genetic requirement for pneumococcal ear infection.

Authors:  Huaiqing Chen; Yueyun Ma; Jun Yang; Christopher J O'Brien; Scott L Lee; Joseph E Mazurkiewicz; Sauli Haataja; Jing-Hua Yan; George F Gao; Jing-Ren Zhang
Journal:  PLoS One       Date:  2007-08-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.